Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

592 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.
Mitnick CD, Rodriguez CA, Hatton ML, Brigden G, Cobelens F, Grobusch MP, Horsburgh R, Lange C, Lienhardt C, Oren E, Podewils LJ, Seaworth B, van den Hof S, Daley CL, Gebhard AC, Wares F; RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative). Mitnick CD, et al. Among authors: grobusch mp. PLoS One. 2016 May 25;11(5):e0155968. doi: 10.1371/journal.pone.0155968. eCollection 2016. PLoS One. 2016. PMID: 27223622 Free PMC article. Review.
Outcomes of multidrug-resistant tuberculosis in Zambia: a cohort analysis.
Kapata N, Grobusch MP, Chongwe G, Chanda-Kapata P, Ngosa W, Tembo M, Musonda S, Katemangwe P, Bates M, Mwaba P, Zumla A, Cobelens F. Kapata N, et al. Among authors: grobusch mp. Infection. 2017 Dec;45(6):831-839. doi: 10.1007/s15010-017-1054-8. Epub 2017 Aug 4. Infection. 2017. PMID: 28779436
Bedaquiline for the treatment of drug-resistant tuberculosis.
Bélard S, Heuvelings CC, Janssen S, Grobusch MP. Bélard S, et al. Among authors: grobusch mp. Expert Rev Anti Infect Ther. 2015 May;13(5):535-53. doi: 10.1586/14787210.2015.1021785. Epub 2015 Mar 22. Expert Rev Anti Infect Ther. 2015. PMID: 25797824 Review.
Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial.
Manabe YC, Worodria W, van Leth F, Mayanja-Kizza H, Traore AN, Ferro J, Pakker N, Frank M, Grobusch MP, Colebunders R, Cobelens F. Manabe YC, et al. Among authors: grobusch mp. Am J Trop Med Hyg. 2016 Dec 7;95(6):1265-1271. doi: 10.4269/ajtmh.16-0239. Epub 2016 Oct 17. Am J Trop Med Hyg. 2016. PMID: 27928077 Free PMC article. Clinical Trial.
The Second Zambian National Tuberculosis Drug Resistance survey - a comparison of conventional and molecular methods.
Kapata N, Mbulo G, Cobelens F, de Haas P, Schaap A, Mwamba P, Mwanza W, Muvwimi M, Muyoyeta M, Moyo M, Mulenga L, Grobusch MP, Godfrey-Faussett P, Ayles H. Kapata N, et al. Among authors: grobusch mp. Trop Med Int Health. 2015 Nov;20(11):1492-1500. doi: 10.1111/tmi.12581. Epub 2015 Aug 27. Trop Med Int Health. 2015. PMID: 26224169 Free article.
592 results